Vanguard Group Inc Soligenix, Inc. Transaction History

Vanguard Group Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 10, 2023	BUY	$0.4 - $168.0 $312 - $131,208	781 Added 0.05%	1,641,026 $738,000
Q2 2022 Aug 12, 2022	SELL	$0.4 - $0.75 $1,106 - $2,075	-2,767 Reduced 0.17%	1,640,245 $984,000
Q4 2021 Feb 14, 2022	SELL	$0.66 - $1.1 $5,883 - $9,806	-8,915 Reduced 0.54%	1,643,012 $1.08 Million
Q3 2021 Nov 12, 2021	BUY	$0.9 - $1.31 $4,167 - $6,066	4,631 Added 0.28%	1,651,927 $1.75 Million
Q2 2021 Aug 13, 2021	BUY	$0.87 - $1.58 $1.43 Million - $2.6 Million	1,647,296 New	1,647,296 $1.83 Million

Ticker SNGX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,105,200
Market Cap $125M
Description
Soligenix, Inc., a late-stage biopharmaceutical company, focuses on developing and commercializing products to treat rare diseases in the United States. It operates in two segments, Specialized BioTherapeutics and Public Health Solutions. The Specialized BioTherapeutics segment develops SGX301 (HyBryte), a novel photodynamic therapy, which has c...

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

Stay updated on Vanguard Group Inc with notifications on news.